Artemis Investment Management LLP Sells 17,478 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Artemis Investment Management LLP cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 53.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,196 shares of the company’s stock after selling 17,478 shares during the quarter. Artemis Investment Management LLP’s holdings in HCA Healthcare were worth $4,561,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Clarius Group LLC boosted its position in HCA Healthcare by 19.1% in the fourth quarter. Clarius Group LLC now owns 1,540 shares of the company’s stock worth $462,000 after purchasing an additional 247 shares during the last quarter. Arkadios Wealth Advisors boosted its holdings in shares of HCA Healthcare by 46.9% in the 4th quarter. Arkadios Wealth Advisors now owns 3,435 shares of the company’s stock worth $1,031,000 after buying an additional 1,096 shares during the last quarter. Canoe Financial LP increased its holdings in HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after buying an additional 231,492 shares during the last quarter. Merit Financial Group LLC grew its position in shares of HCA Healthcare by 137.7% during the 4th quarter. Merit Financial Group LLC now owns 1,569 shares of the company’s stock valued at $471,000 after acquiring an additional 909 shares during the period. Finally, Wedge Capital Management L L P NC raised its holdings in shares of HCA Healthcare by 7.7% in the 4th quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company’s stock worth $34,840,000 after purchasing an additional 8,329 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.4 %

NYSE HCA opened at $310.60 on Monday. The company has a market capitalization of $78.68 billion, a price-to-earnings ratio of 13.95, a PEG ratio of 1.03 and a beta of 1.64. The stock’s 50-day simple moving average is $316.69 and its two-hundred day simple moving average is $353.01. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $278.50 and a twelve month high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Stockholders of record on Friday, December 13th were issued a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Transactions at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of several research reports. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. KeyCorp reduced their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. TD Cowen cut their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.